The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Options

1 Oct 2012 07:00

RNS Number : 5255N
Sopheon PLC
01 October 2012
 



FOR IMMEDIATE RELEASE

1 October 2012

 

SOPHEON PLC

 

GRANT OF OPTIONS

 

Sopheon plc ("Sopheon" or " the Company") announces that it has granted options over ordinary shares of 5 pence each in the share capital of the Company ("Ordinary Shares") to certain directors. These grants are part of a wider grant of options over 5,285,598 Ordinary Shares, to both new and existing staff members.

 

Of this total, options over 285,000 Ordinary Shares have been granted to new members of staff. The remaining 5,000,598 have been granted to members of staff that have been with the company for ten years or longer. This second category represents the replacement of options previously granted to these members of staff approximately ten years ago, of which 146,112 lapsed in 2011 and 4,854,486 have lapsed in 2012 or are due to lapse in 2013. As part of this event, the options due to lapse in 2013 have been cancelled. Accordingly, the vast majority of this category can be considered as replacement or continuation of options in existence at December 31, 2011 and included in our financial statements as of that date.

 

Four directors are involved in this event. Barry Mence has been granted options over 122,500 ordinary shares, Andrew Michuda over 2,767,594, Arif Karimjee over 462,500 and Bernard Al over 25,000 ordinary shares. Following this grant, Barry Mence has options over a total of 485,000 ordinary shares, Andrew Michuda over 3,997,000, Arif Karimjee over 1,150,000 and Bernard Al over 25,000 ordinary shares.

 

All the options will vest evenly over 3 years, and are exercisable up to 10 years from the date of grant. The options have been granted at a price of 5.25 pence per share, being the mid-market closing price on AIM on 28 September 2012.

 

Chairman Barry Mence said:

 

"We are proud of the fact that we have so many staff that have been with us for ten years or longer, and have shown such commitment to our company and our vision. It is right that share option incentives which are due to lapse without exercise are renewed, with vesting conditions designed to encourage continued commitment to the company."

 

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Henrik Persson / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Guy McDougall / Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services. Sopheon's solutions structure, align and manage innovation processes to help organizations generate more revenues and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Corning, Electrolux, Honeywell, Lockheed Martin, Philips and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAXNPAEEAEFF
Date   Source Headline
24th Jul 20199:05 amRNSSecond Price Monitoring Extn
24th Jul 20199:00 amRNSPrice Monitoring Extension
24th Jul 20197:00 amRNSTrading Update
13th Jun 20191:06 pmRNSResult of AGM
13th Jun 20197:00 amRNSAccolade 12.3
13th Jun 20197:00 amRNSAGM Statement
11th Jun 20191:32 pmRNSIssue of Equity
15th May 20197:00 amRNSSopheon Expands Customer Foothold in Asia
13th May 20199:14 amRNSIssue of Equity
28th Mar 20197:00 amRNSSopheon and National Foods Limited Partnership
21st Mar 20197:00 amRNSFinal Results
5th Feb 20197:00 amRNSIssue of Equity
29th Jan 20197:00 amRNSTrading Update
24th Jan 20194:41 pmRNSSecond Price Monitoring Extn
24th Jan 20194:35 pmRNSPrice Monitoring Extension
17th Jan 20197:00 amRNSAccolade Release 12.2
11th Jan 20197:00 amRNSTrading Update
8th Jan 20197:00 amRNSSopheon Partners with The Hershey Company
18th Dec 20182:53 pmRNSIssue of Equity
16th Nov 201812:54 pmRNSIssue of Equity
31st Oct 20185:18 pmRNSIssue of Equity
23rd Oct 20187:00 amRNSSopheon Awarded The Nature's Bounty Co. Business
8th Oct 20189:05 amRNSSecond Price Monitoring Extn
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSTrading Update
10th Sep 20187:00 amRNSDoosan Bobcat Awards Sopheon Innovation Contract
7th Sep 20185:48 pmRNSIssue of Equity
29th Aug 20183:54 pmRNSIssue of Equity & Holdings in Company
28th Aug 20187:00 amRNSAccolade Enterprise Innovation Management
23rd Aug 20187:00 amRNSHalf Yearly Report
19th Jul 201811:05 amRNSSecond Price Monitoring Extn
19th Jul 201811:00 amRNSPrice Monitoring Extension
19th Jul 20187:00 amRNSTrading Update
5th Jul 20189:40 amRNSGrant of Options / PDMR Dealing
3rd Jul 20189:24 amRNSIssue of Equity
13th Jun 20182:37 pmRNSIssue of Equity
7th Jun 201812:09 pmRNSResult of AGM
7th Jun 20187:00 amRNSAGM Statement
31st May 20182:56 pmRNSIssue of Equity
17th May 20188:01 amRNSResult of Secondary Placing
16th May 20183:05 pmRNSProposed Secondary Placing
15th May 20187:00 amRNSIssue of Equity
27th Apr 20183:59 pmRNSIssue of Equity
29th Mar 20187:00 amRNSAccolade Release 12.0
23rd Mar 20183:56 pmRNSIssue of Equity
23rd Mar 20187:00 amRNSIssue of Equity
22nd Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSSopheon named in Annual Reader's Choice List
12th Feb 20189:24 amRNSGrant of Options / PDMR dealing
5th Feb 20183:35 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.